PROGEN is a Germany based startup founded in 1983, dedicated to revolutionizing the life sciences and gene therapy industries. With the slogan "Making life sciences better. Together," PROGEN aims to support scientists in their quest for new discoveries and groundbreaking research in the field. The company prides itself on being more than just a manufacturer of antibodies, proteins, and ELISAs kits. It boasts a team of experts within AAV and life sciences, along with global partnerships with gene therapy specialists. This ensures that PROGEN can understand and cater to the needs of scientists, delivering high-quality antibody and exclusive AAV products in academia, biotech, and pharma. Although the specific details of their last investment and the investors remain unknown, PROGEN continues to strive towards its underlying mission of progressing new therapies safely, quickly, and affordably, to provide solutions for those suffering from poor health and disease. For further information, readers can visit the website www.progen.com or refer to their Imprint: https:\/\/bit.ly\/3uEZf2h and Privacy Statement: https:\/\/bit.ly\/3dMSgxm.
There is no investment information
No recent news or press coverage available for PROGEN.